Personalized Care Pathway May Ease Mood Symptoms In Epilepsy
Researchers tested whether a risk-stratified care pathway could be added to routine epilepsy care for adults who also had clinically relevant symptoms of depression or anxiety.
-
-
Vagus Nerve Stimulation May Lower Brain Vessel Resistance
Researchers looked at whether turning vagus nerve stimulation (VNS) on or off changed brain blood flow-related measurements in people with drug-resistant epilepsy.
-
Devices & Neuromodulation | Drug-Resistant Epilepsy | Epilepsy Research Summaries | Genetics | New Studies
Eye Tracking May Reveal Hidden Thinking Problems In Epilepsy
This paper was a systematic review, which means the authors gathered and summarized earlier studies rather than testing one new group of patients.
-
Epilepsy Research Summaries | Genetics | Ketogenic Diet | New Studies | Pediatrics | Safety & First Aid
Keto Diet May Help Some Teens And Adults With Epilepsy
This study was a systematic review and meta-analysis.
-
Genetic Causes Found In Many Kazakhstan Children With Epilepsy
This study looked at 31 children seen at one tertiary referral center in Kazakhstan for epilepsy or epilepsy-associated neurodevelopmental disorders who were found to have genetic findings considered clinically relevant or potentially relevant.
-
EEG Changes May Signal Seizure Risk In Autism
This study looked at whether epilepsy in children with autism spectrum disorder (ASD) was associated with results from neurologic evaluations, including EEG, brain imaging, genetic testing, and developmental assessments.
-
Immune Activity Near Brain Lesions Linked To Childhood Epilepsy
This case-control study looked at whether a brain-related immune area near the skull shows signs of activation in children with focal lesional epilepsy.
-
Levetiracetam First-Line Choice: Source Note
Source note: the cited Neurology item is an editorial with no PubMed abstract. The previous research-summary format has been removed because its source basis was insufficient.
-
Fenfluramine May Reduce Seizures in Some Severe Epilepsies
This paper combined results from 20 studies of fenfluramine in people with developmental and epileptic encephalopathies (DEEs), a group of severe epilepsy conditions.
